FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to a compound methyl [(1S)-1-{(2S)-2-[5-(4'-{2-[(2S)-1-{(2S,3R)-3-methoxy-2-[(methoxycarbonyl)amino]butanoyl}-pyrrolidin-2-yl]-1H-imidazol-5-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-2-methylpropyl]carbamate of formula 1 and its pharmaceutically acceptable salts
         
      
Also disclosed are methods of producing a compound of formula 1, a pharmaceutical composition based thereon and a method of treating hepatitis C.
EFFECT: obtaining a novel organic compound having the properties of a panthenotypic NS5A HCV inhibitor.
9 cl, 2 tbl, 7 ex
             
         
            
              
                | Title | Year | Author | Number | 
							
              
                | ALKYL [2-(2-{5-[4-(4-{2-[1-(2-METHOXYCARBONYLAMINO-ACETYL)-PYRROLIDIN-2-YL]-3H-IMIDAZOL-4-YL}-PHENYL)-BUTA-1,3-DIINYL]-1H-IMIDAZOL-2-YL}-PYRROLIDIN-1-YL)-2-OXO-ETHYL]-CARBAMATE, PHARMACEUTICAL COMPOSITION, MEDICATION, METHOD OF TREATING VIRAL DISEASES | 2013 | 
										Ivashchenko Aleksandr Vasil'EvichMit'Kin Oleg Dmitrievich | RU2518369C1 | 
							
              
                | ALKYL [(S)-1-((S)-2-{5-[4-(4-{2-[(S)-1-((S)-2-METHOXYCARBONYLAMINO-3-METHYL-BUTYRYL)-PYRROLIDIN-2-YL]-3H-IMIDAZOL-4-YL}-BUTA-1,3-DIINYL)-PHENYL]-1H-IMIDAZOL-2-YL}-PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL]-CARBAMATE NAPHTHALENE-1,5-DISULPHONATE, PHARMACEUTICAL COMPOSITION, MEDICINAL AGENT, METHOD OF TREATING VIRAL DISEASES | 2013 | 
										Ivashchenko Aleksandr Vasil'Evich | RU2507201C1 | 
							
              
                | ANTIVIRAL COMPOSITION AND METHOD OF ITS APPLICATION | 2017 | 
										Aleksandr Vasilevich IvashchenkoMitkin Oleg Dmitrievich | RU2650610C1 | 
							
              
                | PAN-GENOMIC INHIBITORS OF THE HEPATITIS C VIRUS PROTEIN NS5A, PHARMACEUTICAL COMPOSITIONS, INTERMEDIATES FOR THE SYNTHESIS OF INHIBITORS, AND METHODS FOR THEIR PREPARATION AND USE | 2016 | 
										Aleksandr Vasilevich IvashchenkoMitkin Oleg Dmitrievich | RU2669919C1 | 
							
              
                | PRODRUG OF POLYMERASE NS5B HCV INHIBITOR, METHOD FOR ITS PREPARATION AND APPLICATION | 2017 | 
										Ivashchenko Aleksandr VasilevichMitkin Oleg Dmitrievich | RU2644156C1 | 
							
              
                | NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION | 2017 | 
										Aleksandr Vasilevich IvashchenkoMitkin Oleg Dmitrievich | RU2659388C1 | 
							
              
                | SUBSTITUTED AZOLES, ANTIVIRAL ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION, SYNTHESIS AND APPLICATION METHOD | 2010 | 
										Ivashchenko Aleksandr Vasil'EvichBychko Vadim Vasil'EvichMit'Kin Oleg Dmitrievich | RU2452735C1 | 
							
              
                | CYCLOBUTYL (S)-2-[[[R)-2-(6-AMINOPURIN-9-YL)-1-METHYL-ETOXY]METHYL-PHENOXY-PHOSPHORYL]AMINO]-PROPANOATES, METHOD OF THEIR PRODUCTION AND APPLICATION | 2017 | 
										Aleksandr Vasilevich IvashchenkoMitkin Oleg Dmitrievich | RU2647576C1 | 
							
              
                | ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 | 
										Ivashchenko Andrej AleksandrovichIvashchenko Aleksandr VasilevichMitkin Oleg DmitrievichSavchuk Nikolaj Filippovich | RU2717101C1 | 
							
              
                | NUCLEOSIDE INHIBITORS OF RNA-POLYMERASE HCV NS5B, METHODS FOR PRODUCTION AND USE THEREOF | 2014 | 
										Ivashchenko Aleksandr Vasil'Evich | RU2567854C1 |